Ninlaro
Chemical Name | ixazomib |
Dosage Form | Capsule (oral; 2.3 mg, 3 mg, 4 mg) |
Drug Class | Inhibitors |
System | Blood |
Company | Millennium Pharms |
Approval Year | 2015 |
Indication
- In combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received at least one prior therapy.